Cargando...
Response biomarkers: re-envisioning the approach to tailoring drug therapy for cancer
BACKGROUND: The rapidly expanding arsenal of chemotherapeutic agents approved in the past 5 years represents significant progress in the field. However, this poses a challenge for oncologists to choose which drug or combination of drugs is best for any individual. Because only a fraction of patients...
Guardado en:
| Publicado en: | BMC Cancer |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5097425/ https://ncbi.nlm.nih.gov/pubmed/27814715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2886-9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|